https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:14:352016-05-17 14:14:19An exploration of how male adolescents who had childhood cancer make sense of infertility as a long-term effect of cancer treatments
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:14:072016-05-17 14:14:22The impact of pCODR on cancer drug funding decisions
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:13:272016-05-17 14:14:26What Can We Learn About Rare Cancers? An Example from Brain Tumours
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:12:582016-05-17 14:14:29CARES: Improving breast and cervical screening among marginalized women through a multi-faceted community intervention
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:11:232016-05-17 14:14:32Provincial elections and timing of cancer drug funding
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:11:062016-05-17 14:14:38Identifying the most effective multi-attribute utility instruments to guide cancer funding decisions in Canada
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:10:012016-05-17 14:17:10Communities of Practice: A knowledge transfer and exchange model for improving quality of care in radiation treatment
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:08:252016-05-17 14:17:17Estimating the costs of intensity-modulated and 3D conformal radiotherapy in Ontario
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 12:08:052016-05-17 14:15:28Estimating the effect of time on patient-derived measures of quality of life and health state utility
https://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.png00Rebecca Mercerhttps://cc-arcc.ca/wp-content/uploads/2014/11/ARCC_Logo_Horizonta2l.pngRebecca Mercer2016-05-17 11:46:282016-05-17 14:15:31Developing a disease pathway map for the diagnostic process of soft tissue sarcomas
Connect With Us!